Submitting OIG:
Report Description:
Indiana did not always comply with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs. Indiana did not invoice manufacturers for rebates associated with $710,420 (Federal share) in physician-administered drugs. Of this amount, $695,070 was for single-source drugs, and $15,350 was for top-20 multiple-source drugs. Because Indiana's internal controls did not always ensure that it invoiced manufacturers to secure rebates, Indiana improperly claimed Federal reimbursement for these single-source drugs and top-20 multiple-source drugs.
Date Issued:
Friday, April 5, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-05-17-00038
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
Questioned Costs:
$710,420
Number of Recommendations:
7
View Document:
Attachment | Size |
---|---|
51700038.pdf | 2.29 MB |
Additional Details Link: